Why Hims & Hers Health, Inc. (HIMS) Stock Fell 5.4% on Nov 17, 2026
as of Tuesday, 12:33 PM ET
The reason we found
Hims & Hers Drops on Profitability Concerns After Earnings
Although revenue rose 49% to $890.4 million, Hims & Hers swung to a $33 million net loss and gross margin fell to 57%. Reports highlighting weaker profitability and a 100,000-subscriber decline plausibly drove the nearly 6% drop as investors reassessed the company’s growth quality.
earningshigh confidence
Sources 9
- Hims & Hers Stock Fell 32% As Profit Slippedtrefis.com
- Hims & Hers Stock Fell 32% As Profit Slipped - Trefisnews.google.com
- Hims & Hers Health, Inc. (HIMS) Stock Price, News, Quote & History - Yahoo! Finance Canadanews.google.com
- Hims & Hers Stock Fell 32% As Profit Slippedfinnhub.io
- Hims & Hers Health (HIMS) Added FDA Approved Obesity Drugs To Its Platformfinnhub.io
- Hims & Hers Health Stock Crashes After Earnings: Is Now the Time to Buy?nasdaq.com
- Hims & Hers Health Stock Crashes After Earnings: Is Now the Time to Buy?fool.com
- Hims & Hers Health Stock Crashes After Earnings: Is Now the Time to Buy?finnhub.io
- Hims & Hers Lost 100K Subscribers Before Adding Eli Lilly’s $299 Zepbound: Buy the Dip, or Wait?finnhub.io
Our call
Sell somedated Nov 20, 2026
Hims & Hers Health fell 26% over the past five trading days, far more than other health care stocks (down 6.3%), and its report on Nov 9 missed profit forecasts by 57%. We'd stop selling if Hims & Hers Health's next report beats profit forecasts.
Other moves on Nov 17
- SLS+156.8%SELLAS surges after leukemia vaccine succeeds in Phase 3 trial
- SPCE−17.3%Virgin Galactic Slides After Analysts Cut Price Targets
- ACM+11.1%AECOM jumps on earnings beat and stronger 2027 outlook
- CRM−9.4%Salesforce Slides on Engineering Chief Departure and AI Fears
- MNSO+8.3%MINISO reports strong nine-month revenue growth despite Q3 misses
- ENPH−7.5%Evercore cuts Enphase price target to $30